Novo Nordisk is providing direct-to-patient delivery of Wegovy (semaglutide) through the NovoCare Pharmacy program.
Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...
New York, New York-- (Newsfile Corp. - March 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, ...
How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...
A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...
"We are currently engaging with market participants," a spokesperson for South Africa's Competition Commission told Reuters, declining to provide details. USAID cuts put tuberculosis response in peril ...
The last few years have been tough for the insulin market, with recent policies and high-level pressure forcing companies to ...
This growth comes on the back of a steady market performance from 2017 to 2022, where the injection pen sector achieved a ...
10d
California dedicated $100 to manufacturing insulin for diabetic residents. That effort is taking longer than Gov. Gavin ...
During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback